Craig-Hallum Downgrades Silvergate Capital to Hold, Lowers Price Target to $14
Craig-Hallum analyst George Sutton downgrades Silvergate Capital (NYSE:SI) from Buy to Hold and lowers the price target from $36 to $14.
Morgan Stanley Downgrades Agiliti to Equal-Weight, Announces $18 Price Target
Morgan Stanley analyst Drew Ranieri downgrades Agiliti (NYSE:AGTI) from Overweight to Equal-Weight and announces $18 price target.
B of A Securities Downgrades Silvergate Capital to Underperform, Lowers Price Target to $8
B of A Securities analyst Brandon Berman downgrades Silvergate Capital (NYSE:SI) from Neutral to Underperform and lowers the price target from $37 to $8.
B of A Securities Downgrades Fate Therapeutics to Underperform, Lowers Price Target to $4
B of A Securities analyst Tazeen Ahmad downgrades Fate Therapeutics (NASDAQ:FATE) from Buy to Underperform and lowers the price target from $72 to $4.
Stifel Downgrades Fate Therapeutics to Hold, Lowers Price Target to $5.3
Stifel analyst Benjamin Burnett downgrades Fate Therapeutics (NASDAQ:FATE) from Buy to Hold and lowers the price target from $107 to $5.3.
Wells Fargo Downgrades Ballard Power Systems to Underweight, Raises Price Target to $5
Wells Fargo analyst Praneeth Satish downgrades Ballard Power Systems (NASDAQ:BLDP) from Equal-Weight to Underweight and raises the price target from $6 to $5.
Wells Fargo Downgrades Ulta Beauty to Underweight, Lowers Price Target to $400
Wells Fargo analyst Ike Boruchow downgrades Ulta Beauty (NASDAQ:ULTA) from Equal-Weight to Underweight and lowers the price target from $450 to $400.
Morgan Stanley Downgrades Baxter Intl to Equal-Weight, Announces $55 Price Target
Morgan Stanley analyst Cecilia Furlong downgrades Baxter Intl (NYSE:BAX) from Overweight to Equal-Weight and announces $55 price target.
Morgan Stanley Downgrades Doximity to Underweight, Lowers Price Target to $29
Morgan Stanley analyst Ricky Goldwasser downgrades Doximity (NYSE:DOCS) from Equal-Weight to Underweight and lowers the price target from $32 to $29.
Scotiabank Downgrades Confluent to Sector Perform, Announces $21 Price Target
Scotiabank analyst Nick Altmann downgrades Confluent (NASDAQ:CFLT) from Sector Outperform to Sector Perform and announces $21 price target.